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Psoriasis is a chronic skin disease characterized by epidermal hyperproliferation, 
disturbed differentiation, and inflammation. It is still a matter of debate whether 
the pathogenesis of psoriasis is based on immunological mechanisms, on defec­
tive growth control mechanisms, or possibly on a combination of both. Several in 
vivo cell biological differences between psoriatic lesional epidermis and normal 
epidermis have been reported. However, it is not clear whether these changes 
are causal or consequential. In case that keratinocytes from psoriatic patients have 
genetically determined deficiencies or polymorphisms with respect to autocrine 
growth regulation and the response to inflammatory cytokines, we hypothesize 
that these differences should be maintained in culture. Here we have started a 
systematic comparison of first passage keratinocytes cultured from normal skin 
and uninvolved psoriatic skin to address the question whether there are intrinsic 
differences in basic cell cycle parameters. In an established, defined culture 
system using keratinocyte growth medium (KGM) we have determined: (i) cell 
cycle parameters of exponentially growing keratinocytes, (ii) induction of quies­
cence by transforming growth factor (Jj (TGF-p,), and (iii) restimulation from the 
Go-phase of the cell cycle. Bivariate analysis of lodo-deoxyuridine incorporation 
and relative DNA content was performed by flow cytometry. Within the limita­
tions of this model no gross differences were found between normal and psoriatic 
keratinocytes with respect to S-phase duration (Ts), total cell cycle duration (Tc), 
responsiveness to TGF-fi, and the kinetics for recruitment from G0. In psoriatic 
keratinocytes we found a lower amount of cells in S-phase and a shorter duration 
of Gw compared to normal keratinocytes. The methodology developed here 
provides us with a model for further studies on differences between normal and 
psoriatic keratinocytes in their response to immunological and inflammatory me­
diators, © 1996 Wiley-Uss, Inc.
Psoriasis is a polygenic, chronic skin disease of un­
known etiology, affecting approximately 2—4% of the 
world population (van de Kerkhof, 1986). The disease 
is characterized by a marked increase in keratinocyte 
proliferation (Weinstein and van Scott, 1965), abnor­
mal patterns of keratinocyte differentiation (Bernard 
et al., 1988), prominent alterations in dermal capillary 
vasculature (Braverman and Sibley, 1982), and the 
presence of dermal and epidermal T-cells, monocytes, 
macrophages, and polymorphonuclear leukocytes 
(PMNs; Hammar et alv 1984; Baker et al., 1984). Many 
in vivo cell biological differences between psoriatic le­
sional epidermis and normal epidermis have been re­
ported. In psoriatic epidermis, a number of molecules 
that are absent in normal skin are strongly expressed 
(e.g., cytokeratins [CK] 6, 16, and 17 [de Jong et al., 
1991; Weiss et al., 1984; De Mare et al., 1989], and the 
epidermal proteinase inhibitor SKALP which we have 
recently described [Alkemade et al., 1994; Molhuizen 
et al., 1993]). In addition, several molecules have a
restricted expression pattern in normal skin, but are 
highly upregulated in psoriatic skin (e.g., psoriasis-as- 
sociated fatty acid binding protein [PA-FABP; Madsen 
et al., 1992], psoriasin [Madsen et al., 1991], trans­
forming growth factor a  [TGF-a; Turbitt et al., 1990; 
Elder et al., 1989], amphiregulin [Cook et al., 1992], 
epidermal growth factor receptor [EGF-R; Nanney et 
al., 1992], interleukin Ira [Hammerberg et al., 1992], 
interleukin ip  [Schmid et al., 1993], interleukin 6 and 
8 [Nickoloff et al., 1991; Grossman et al., 1989], GRO 
a/p/y [Tettelbach et al.} 1993], and fibronectin [Bernard 
et al., 1988]), or show a sustained expression (e.g., the 
oii$5 integrin [Hertle et al., 1992; Pellegrini et al.,
1992]), or are prematurely expressed (e.g., involucrin 
[Bernard et al., 1988] and transglutaminase [Michel et
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al., 1992]). It is not clear whether these differences 
are involved in the pathogenetic process or are a mere 
consequence of the disease process.
Two main views exist on the etiology of psoriasis. 
Psoriasis could be based on immunological mechanisms 
(Gottlieb, 1990; Gottlieb et al., 1995; Grossman et al., 
1989; Schmid et al., 1993) or, alternatively, psoriasis 
may be caused by defective growth control mechanisms 
(Gentleman et al., 1984; Nanney et al., 1986; Elder et 
al., 1989). Because of the presumed polygenic nature 
of the disease, these views cannot be strictly separated 
(Elder et al,, 1994), and psoriasis could very well be 
caused by a combination of genetic polymorphisms af­
fecting the immune response and an increased sensitiv­
ity of psoriatic keratinocytes to T-cell derived cytokines 
(Bata-Csorgo et al., 1995; Leung et al., 1993; Baads- 
gaard et al., 1990). We hypothesized that if keratino­
cytes from psoriatic patients harbor genetically deter­
mined deficiencies or polymorphisms with respect to 
autocrine growth regulation and their response to in­
flammatory cytokines, these differences are main­
tained in culture, and we should be able to quantify 
the abnormalities keratinocytes cultured from the clini­
cally unaffected skin. In order to address these ques­
tions, we have started a systematic comparison of first 
passage cultured human keratinocytes derived from 
normal healthy epidermis and uninvolved psoriatic epi­
dermis. Using bivariate flow cytometry, a method 
which allows accurate quantitative characterization of 
cell populations, we have determined cell cycle parame­
ters of exponentially growing keratinocytes, induction 
of quiescence by addition of transforming growth factor 
pi, and restimulation from the G0-phase (quiescence) 
of the cell cycle.
MATERIALS AND METHODS 
Biopsies
Biopsies (0.2-mm thickness) from healthy volunteers 
and volunteers with psoriasis were taken with a kera- 
tome as previously described (Schalkwijk et al., 1990) 
and used for primary keratinocyte cultures.
Keratinocyte primary culture
Human epidermal keratinocytes were initially cul­
tured according to the Rheinwald-Green system 
(Rheinwald and Green, 1975). Primary cultures of ker­
atinocytes were seeded on lethally irradiated (3,000 
rad, 3 min) Swiss mouse 3T3 fibroblasts in DMEM/T?12 
(3:1) (v/v; Flow Laboratories, Irvine, Scotland) supple­
mented with 0.4 |LLg/ml hydrocortisone (Collaborative 
Research Inc., Lexington, MA), isoproterenol (10-6 M; 
Sigma, St. Louis, MO), 100 U/ml penicillin plus 100 fig/ 
ml streptomycin (Gibco, Breda, The Netherlands), 6% 
fetal calf serum (FCS; Seralab, Nistelrode, The Nether­
lands), and 10 ng/ml mouse epidermal growth factor 
(EGF; Sigma), Cells were grown at 37°C, 95% relative 
humidity and 8% C02 in air. EDTA-treated, trypsinized 
and liquid nitrogen-stored keratinocytes from the pri­
mary culture were used in further experiments.
Keratinocyte secondary culture
For the experiments, the human keratinocytes were 
seeded at 106 cells in Keratinocyte Growth Medium 
(KGM) in 60-mm culture dishes. KGM was composed 
of Keratinocyte Basal Medium (KBM) (Clonetics, San
Diego, CA; 0.15 mM calcium) supplemented with etha- 
nolamine (0.1 mM; Sigma), phosphoethanolamine (0.1 
mM; Sigma), bovine pituitary extract (BPE; 0.4% v/v; 
Clonetics), EGF (10 ng/ml; Sigma), insulin (5 jAg/ml; 
Sigma), hydrocortisone (0.5 jig/ml; Collaborative Re­
search Inc.), penicillin (100 U/ml; Gibco), and strepto­
mycin (100 |Lig/ml; Gibco). Cultures were grown at 37°C, 
95% relative humidity and 5% C 02 in air.
K eratinocyte grow th arrest
For experiments in which cells were required in the 
quiescent state, the medium was removed at 20-30% 
confluence (usually about 5 days), the culture washed 
briefly with phosphate-buffered saline (PBS) supple­
mented with calcium (120 joM; Merck, Darmstadt, Ger­
many), and growth-arrest medium was added as we have 
described previously (van Ruissen et al,, 1994). During 
the experiments we used KGM supplemented with TGF- 
Pt (10 ng/ml; R&D systems Europe Ltd. Abingdon, UK) 
as growth-arrest medium. All cultures were grown at
37°C, 95% relative humidity and 5% C02 in air.
K eratinocyte grow th stim ulation
Growth arrested keratinocyte cultures were washed 
briefly with PBS supplemented with calcium (120 juM) 
to remove TGF-p!, and new growth medium (KGM) was 
added.
IdUrd lab elin g
Cultured keratinocytes were either pulse-labeled (30 
min) or continuously labeled with IdUrd (Sigma), in 
either case at a final concentration of 10 |iM. After pulse 
labeling, the cultures were washed twice with PBS sup­
plemented with calcium (120 |iM) and refed with fresh 
medium. Experiments were terminated by washing the 
cultures twice with PBS followed by one wash with 0.25% 
trypsin (DIFCO Laboratories, Detroit, MI), 0.02% EDTA, 
and 0.1% glucose. After 15 min incubation with the same 
solution (to allow complete detachment of cells), the cells 
were collected in PBS containing 5% FCS. After centrifu­
gation the keratinocytes were fixed by resuspending the 
pellet in 70% ethanol (—20°C), and the suspension was 
stored at —20°C until further use.
Im m unocytochem ical sta in in g  
o f IdUrd and DNA lab elin g
Staining was basically as previously described (van 
Erp et al., 1988). In brief, about 105 ethanol-fixed cells 
were washed once with phosphate-buffered saline sup­
plemented with 1% heat-inactivated normal calfs se­
rum  (PBS/HINCS). The cells were hydrolyzed for 30 
min at room temperature with 0.1 mg/ml pepsin in 2 
N HC1. Hydrolysis was terminated with excess 1 M 
TRIZMA base (Sigma). The cells were pelleted and 
washed with PBS containing 0.1% Nonidet P40 (BDH 
Chemicals Ltd*, Poole, England). After sedimentation, 
the cells were incubated with a 1:50 dilution of the 
monoclonal antibody DAKO-BrdUrd (Dakopatts, Co­
penhagen, Denmark) for 30 min. This monoclonal anti­
body specifically detects BrdUrd and IdUrd. After 
washing the cells with PBS/HINCS, a second incuba­
tion step (15 min, 4°C) using a 1:50 dilution of fluores­
cein isothiocyanate-conjugated rabbit anti-mouse im­
munoglobulins (RAM-FITC; Dakopatts) containing 3% 
normal rabbit serum (NRS), was carried out to visual-
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ize the IdUrd incorporation. Following a final wash 
with PBS/HINCS, the cells were resuspended in 300 jil 
PBS containing 40 jig/ml propidium iodide (PI; Calbio- 
chem, San Diego, CA) and incubated for 15 min with 
50 |il of 1% (w/v) RNAse A (Sigma).
Flow cytom etry
Cells stained with PI and fluoresceine isothiocyanate 
(FITC) were analyzed on the Epics® Elite flow cytometer 
(Coulter Corporation, Hialeah, FL) equipped with a 40 
mW air-cooled argon-ion laser set at 15 mW and tuned 
at a wavelength of 488 nm. FITC and PI signals were 
separated by a 550 nm dichroic mirror. The FITC signals 
(green fluorescence) were detected through a 525-nm 
band pass filter, and the PI signals (red fluorescence) 
were detected through a 630-nxn long pass filter.
Usually 104 cells were measured at a flow rate of 
approximately 50 cells per second. The data were re­
corded in listmode and analyzed on the Epics® Elite 
workstation. The ratio area/peak of the red fluorescence 
is an excellent discriminator between artifacts due to 
doublets of diploid cells and real single tetraploid (or 
late S) cells when intact cells are used (Bauer and 
Boezeman, 1983). The data were further analyzed on 
the Epics® Elite workstation with the program Multicy­
cle (Version 2.5; Phoenix Flow Systems, San Diego, CA) 
to determine the percentages of Go/Gi, S and G2/M.
Calculations of cell cycle tim e 
and duration of S-phase
Two-parameter flow cytometry of DNA versus IdUrd 
allows assessment of the number of cells in S-phase 
(Ns) and the duration of the S-phase (Ts) even from one 
single sample (Begg et al., 1985). The calculation of Ts 
is based on the assumption that there is a linear in­
crease in mean relative DNA content of the IdUrd-la- 
beled S-phase cells in time. At time zero after IdUrd 
pulse-labeling, the mean DNA content of the IdUrd- 
labeled S-phase cells is in the middle of the interval 
between the unlabeled diploid G0/G1 cell population and 
the unlabeled tetraploid Ga/M cell population. As the 
IdUrd-labeled cells move through the S-phase, the mean 
DNA content of the population will approach the DNA 
content of the G2/M population. The IdUrd-labeled cells 
which have divided and appeared in the (labeled) diploid 
Gi region were excluded from the calculation of mean 
DNA content. In Figure 1, two examples are given for 
the movement of IdUrd-positive cells through the cell 
cycle. Movement of IdUrd-labeled S-phase cells relative 
to the position of G0/G1 and Ga/M is expressed as relative 
movement (EM) and is calculated as follows:
RM = (FIdUrd FG 07GI )
(Fg2/M F qo/Gi )
( 1 )
where FidUrd (R4) is the mean DNA content of the 
IdUrd-labeled cell (IdUrd-labeled G0/G1 (R3) cells were 
excluded), F Go/gi (R 2 ) is the mean DNA content of the 
unlabeled diploid G0/G1 population (will also contain 
the differentiated cell population, if present) and F G2/m 
(R5) is the mean DNA content of the G2/M cells.
RM will increase in time from RM = 0.5 at time zero 
(IdUrd-labeled cells half-way between the G0/G1 cells 
and the G2/M cells) to RM = 1 when all IdUrd-labeled 
cells have reached tetraploid DNA content. The time
needed for labeled cells to reach tetraploid DNA content 
is equal to Ts. Ts is calculated from one single sample 
using the formula:
T = —
8 (RM
0.5
0.5)
x At (2 )
where At is the time between pulse-labeling and sam­
pling.
The absolute cell cycle time (Tc) can be calculated if 
the cells have a uniform distribution through the vari­
ous phases of the cycle. I t follows that:
Tc = Ts X Ns
Nc
(3)
where Na is the number of cells in S-phase, Nc is the 
number of cycling cells (growth fraction, GF), Ts is the 
duration of the S-phase and Tc is the cell cycle time.
Johansson et al. (1994) recently described a refine­
ment of the method to improve the determination of Ts 
values by correcting for the nonlinearity of the Begg 
approach. We have compared the values of Tc calcu­
lated both according to Begg et al. (1985) and Johans­
son et al, (1994) with our data. The Tc is also measured 
directly as we monitored the movement of IdUrd-posi- 
tive cells through the cell cycle after pulse labeling. To 
make use of all our measured data for each specimen, 
we postulate a function that could approximate the 
movement of IdUrd-positive cells through the middle of 
the S-phase. The pattern of IdUrd-positive cells passing 
through the window in the middle of the S-phase can 
be approximated with a damped oscillation:
y(t) «  e“172* Sini 2]J (4)
\  1  /
where T is the period of the sine function (the cell cycle 
time). If necessary this formula can be adjusted to cal-
~ 4-T________ 11 ~ i-Z_____ £■--- i.U  -  ~ _________________T J T  T_________3
­
culate the cell cycle time for the passing wave of IdUrd- 
positive cells.
S tatistica l analysis
Statistical analysis was performed using the statisti­
cal analysis software from the SAS Institute BV, Hilv­
ersum, in the Netherlands. To estimate the cell cycle 
times, the measured IdUrd percentages were fitted to 
formula 4. For comparison of the different cell cycle 
times and growth restimulation between normal and 
psoriatic uninvolved keratinocytes, we used a two-way 
ANOVA with diagnosis (psoriasis and normal) and 
methods (Begg, Johansson and our model) as factors 
followed by a Duncan's multiple range test. To test 
significances between normal and psoriatic cell cycle 
parameters we used the Student t-test.
RESULTS 
Cell cycle analysis
To determine cell cycle parameters, first-passage hu­
man keratinocytes were cultured in KGM. When cul­
tures reached about 30—40% confluence they were ei­
ther pulse-labeled or continuously labeled with IdUrd. 
Pulse-labeled cultures were harvested at intervals of 4 
hours, during a period of 48 hours. Continuously la­
beled cultures were harvested after 48 hours. From the 
pulse-labeled cultures the percentage of cells in the
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Fig. 1. Dot plot of IdUrd-positive cells after 0 hours and 4 hours of 
pulse labeling. The windows R2, R3, R4 and R5 represent the following 
population of cells; R2, the unlabeled diploid Go!Q\ population (which 
will also contain the differentiated cell population, if present); R3, the 
IdUrd-labeled G./G,; R4, the IdUrd-labeled cells from S and G2M; 
and R5, the unlabeled cells in G/M. These regions are necessary to
calculate the relative movement. At t  = 0 h the figure demonstrates 
tha t the mean of the IdUrd-labeled cells lies in the middle of Go/Gi 
and Gii/M, and at t — 4 h the figure shows the movement of cells from 
the Go/Gi position into the S-G2/M position. Using formulas 1, 2 and 
3, Tb and Tc are calculated.
middle of the S-phase was determined. In Figure 2 a 
typical experiment is shown for the movement of cells 
in time after pulse labeling with IdUrd. This pattern is 
identical for normal and psoriatic keratinocytes. Figure 
3 represents an example of the fraction of IdUrd-labeled 
cells in the middle of the S-phase during normal growth 
in KGM of keratinocytes from normal healthy epidermis. 
The movement of IdUrd-positive cells through the cell 
cycle is similar for psoriatic keratinocytes. The fitted 
curve represents the approximation of the movement of 
IdUrd-positive cells through the middle of the S-phase 
by our proposed model (see Materials and Methods).
We have determined the percentages of actively cycling 
cells (Nc), also known as the growth fraction (GF), using 
a continuous labeling with IdUrd. As previously demon­
strated (van Ruissen et al., 1994) a 48-hour continuous 
label of IdUrd is long enough to ensure that all cycling 
cells incorporate IdUrd into the DNA. Growth fractions 
were in a range of, respectively, 78.8—91.9% and 71.2— 
94.9% for normal human keratinocytes and psoriatic kera­
tinocytes.
In Table 1 we have summarized the cell kinetic pa­
rameters calculated according to Begg et al. (1985). For 
the same cultures we calculated the cell cycle time ac­
cording to formula 4. In this model we make use of all 
the data collected during a 48-hour time period, yield** 
ing a calculated cell cycle time based on 13 timepoints 
measured in duplo. In Table 2 we present our calculated 
cell cycle times for normal keratinocytes and psoriatic 
keratinocytes. Furthermore, we have summarized our 
data obtained from the DNA content analysis and the 
cell cycle parameters calculated from these data.
To compare our data with data derived from Begg et
al. (1985) and Johansson et al. (1994), we performed a 
two-way ANOVA with methods (Begg, Johansson and 
formula 4) and diagnosis (normal or psoriasis) as fac­
tors followed by a Duncans5 multiple range test. From 
this test we could conclude that the diagnosis was not 
significant, but tha t the methods were significantly dif­
ferent. We could not detect a significant difference be­
tween our calculated Tc and the Tc calculated according 
to Begg et al. (1985). Using the calculations proposed 
by Johansson et al. (1994; data not shown) we find 
significantly higher Tc values.
Statistical analysis of cell kinetic data from normal 
and uninvolved psoriatic keratinocytes did not reveal 
significant differences in cell cycle times and the dura­
tion of S-phase, This was found either using the method 
of Begg et al. (1985) or according to our model. We 
observed significant differences between the number 
of cells in the S-phase during normal growth and the 
duration of the G1-phase (see Table 2).
G rowth restim ulation
Keratinocyte cultures were restimulated by removal of 
TGF-pi after 48 hours and addition of fresh growth me­
dium. At successive timepoints 0, 8, 16, and 24 hours 
after restimulation, the cells were harvested for flow cyto­
metric analysis. In the 8 hours prior to each sample point, 
cells were labeled with IdUrd. The number of labeled 
cells is indicative for the number of cells in the cohort and 
the appearance of labeled cells represents the kinetics as 
they move through the cell cycle (illustrated by Fig. 4),
We have to realize that the fraction of labeled cells 
is influenced by Ta> Tc and the labeling duration Tpuise
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Fig. 2. Demonstration of the movement of IdUrd-positive cells 
through the cell cycle. From, top to bottom and left to right we have 
arranged the plots of green fluorescence (IdUrd) versus red fluores­
cence (PI, DNA content) a t t  = 0, 4, 8,12, 16, 20, 24, 28, and 32 hours 
after pulse labeling. With this figure it is demonstrated that the cells 
move through the cell cycle. At 0 hours after pulse labeling the IdUrd- 
positive cells are positioned between the Go/Gi phase and the Gy/M 
phase. At 4 hours the cells move in towards the G2/M phase and at 8
Fig. 3. Representation of the IdUrd-positive cells in the middle of 
the S-phase. After pulse labeling (30 min) and washing, medium was 
refreshed and cells were harvested over a period of 48 hours, at inter­
vals of 4 hours. The percentage of cells in the middle of the S-phase 
were measured using flow cytometry. The data are represented in 
this figure showing the movement of IdUrd-positive cells through the
hours a population of cells returned into the Gq/Gt phase and a popula­
tion resides in the G-JM. phase (the S-phase is almost empty). Twelve 
hours after labeling almost all IdUrd-positive cells have returned to 
the Go/Gi phase, and at 16 hours cells are entering the S-phase. This 
movement continues during the culture period but is damped at later 
time points, because the IdUrd-positive signal will be dispersed over 
the daughter cells and finally acquires a random distribution over the 
cell cycle.
S-phase. Note that the percentage of cells in the middle of the S-phase 
declines and after a while again reaches a maximum. The distance 
between the maxima represents the duration of one cell cycle. The 
fitted curve represents the function approaching the movement of 
IdUrd-positive cells through the middle of the S-phase as proposed 
by our model.
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TABLE 1. Summary of cell kinetic data calculated according to Begg et al. (1985)
Normal Psoriatic (uninvolved)
LI Ns Nc (GF) T■*-8 T* c LI Ns Nc (GF) TXS T1 c
0.244 22.40 91.90 6.62 27.14 0.261 21.75 83.20 7.58 29.01
0.379 34.05 89.75 5.75 15.16 0.259 21.05 81.35 7.08 27.36
«1 0.378 29.75 78.80 6.83 18.08 0.207 19.70 94.95 5.62 27.09
0.329 30.55 92.75 5.34 16.22 0.233 16.60 71.20 5.29 22.71
0.286 26.30 91.90 7.38 25.78
Mean 0.32 28.61 89.02 6.38 20.48 0.24 19.78 82.68 6.39 26.54
S.D. 0.06 4,43 5.82 0.82 5.58 0.03 2.28 9.74 1.11 2.69
S.E.M. 0.03 1.98 2.60 0.37 2.50 0.01 1.02 4.35 0,50 1.20
TABLE 2. Comparison of cell kinetic data derived from 
keratinocytes cultured in serum-free medium
Normal
Psoriasis
(uninvolved)
Mean S.E.M. Mean S.E.M
Tc2 21.93 3.15 20.77 1.82m 5  ^s 7.17 1.42 4.92 0.20
Ngo3 10.98 2.60 17.33 4.35
Ng,3 50.83 2.46 51.66 3.52
Ngs/m* 12.59 2.29 15.06 0.81
N91,3 25.63 1.86 16.04 1.05
Tg!1’' 11.73 1.53 16.53 0,69
Tgo/m4 3.01 0.82 4.87 0.41m 4 5.74 0.41 5.17 0.39
’Significant difference.
^Determined from direct measurement.
determined from the DNA histogram analysis with multicycle and formula [5|. 
4Determined with the multicycle parameters and the calculated Tt and GF. 
r,Determined from the measured Tc.
of 8 hours. The maximum fraction of labeled cells in an 
asynchronously growing culture can be expressed by
•^labeled _ (T g  T p U]SÜ)
N, T
(5)
As Tg and Tc differ for psoriatic and normal keratino­
cytes, the maxima are 51% and 60% respectively and 
the measured data are normalized in this respect.
Statistical analysis, using a two-way ANOVA (with 
diagnosis and IdUrd percentages as factors) followed by 
a Duncans7 multiple range test (with different sample 
periods as factors), showed no significant difference in 
the kinetics of growth re stimulation of psoriatic unin­
volved and normal keratinocytes.
DISCUSSION
Early studies on keratinocyte proliferation have sug­
gested that basal epidermal cells were equipotent with 
similar cell cycle times and probabilities of cell division. 
However, in later studies it became clear that the basal 
cell population is heterogeneous (reviewed in Dover, 
1994). The main attempt in studies with respect to ker­
atinocyte proliferation was to demonstrate the pres­
ence and localization of stem cells in the epidermis. 
With reference to the epidermis, stem cells are defined 
as keratinocytes with the capacity for unlimited self­
renewal and whose daughters may either be stem cells 
or else be committed to undergo terminal differentia­
tion and (ultimately) become a squame (Watt, 1988). 
At present there is no direct evidence for a stem cell 
population in the basal layer of the epidermis. Several 
publications describe the existence of epidermal stem
cells in the hair follicle (reviewed in Dover, 1994), based 
on the idea that the epidermis may be reepithelialized 
after injury by migration of keratinocytes from the hair 
follicle. Other reports describe the existence of epider­
mal stem cells based on different surface expression of 
Pi-integrins, adhesion to collagen, and colony-forming 
efficiency (Watt and Jones, 1993; Jones and Watt,
1993). A recent report describes the existence of a Pr 
integrin-positive, cytokeratin 1-, cytokeratin 10- and 
PCNA-negative epidermal subpopulation (containing 
stem cells), and a pi-integrin, cytokeratin 1-, and cytok­
eratin 10-positive subpopulation, (transit amplifying 
cells; Bata-Csorgo et al., 1993,1995). From these obser­
vations it is evident that the basal layer of normal epi­
dermis consists of a heterogeneous population of kera­
tinocytes containing progenitor cells that are responsi­
ble for continued local renewal of the epidermis. Some 
of these basal cells become committed to differentiation 
(expressing involucrin) and have the ability to undergo 
several rounds of amplification (transit amplifying 
cells; Wilke et al., 1988a; Bata-Csorgo et al., 1993).
Previously it was believed that the turnover of epi­
dermis was regulated by variations in the cell cycle 
time of the stem cell population and that the GF was 
unity. In 1976, the first argument that germinative 
cells could reside in a noncycling state was presented 
by Gelfant (1976). He introduced the existence of non­
cycling (G0) cells. This hypothesis was confirmed by 
several investigators (Gelfant, 1982; Eaglstein and 
Weinstein, 1975). We have previously shown that be­
tween 36 and 52 hours after tape-stripping, 23% of the 
viable epidermal cells moved as a cohort through the 
cell cycle (Boezeman et al., 1987). Such a well-defined 
cohort only results from a population of diploid cells 
simultaneously entering the cell cycle, meaning that 
these cells have the same starting point in the cell cycle. 
These results indicated that these recruited cells have 
a static position somewhere in the Gi phase of the cell 
cycle, termed the Go phase. It is clear that the epider­
mal cell population comprises two distinct subpopula­
tions termed “cycling” and “quiescent.” The rate of cell 
production is determined by the ratio of these two popu­
lations, called the GF. In normal epidermis the growth 
fraction is around 10% (Bata-Csorgo et al., 1993; van 
Erp et al., 1991); following injury there is a transient 
increase, and in lesions of psoriatic epidermis the 
growth fraction remains permanently increased in the 
range of 50—100%. This concept is supported by a num­
ber of studies using bivariate flow cytometric analysis 
(IdUrd incorporation and DNA content) or the mono-
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Fig. 4. Growth restimulation after induction of quiescence with TGF- 
Pj . Keratinocyte cultures of normal and uninvolved psoriatic keratino­
cytes were growth-arrested with TGF-pi, cultures were washed and 
restimulated with fresh growth medium. Cultures were harvested 
after an 8-hour pulse label, at 0, 8,16, and 24 hours following growth
t'.ï a 'awJ is
Psoriatic keratinocytes
restimulation and analyzed using flow cytometry. The percentages of 
IdUrd-positive cells (y-axis) were normalized according to formula 6. 
The kinetics of growth restimulation of normal and psoriatic keratino­
cytes was not significantly different.
clonal antibody Ki-67 (Rijzewijk et al., 1989; van Erp 
et al., 1989).
During the past decade, many investigators have 
studied cell cycle parameters of human keratinocytes. 
Most of these papers give only ratiometric information 
(i.e., mitotic index and/or labeling index). The data 
given in the literature show a great deviation in the 
observed cell cycle times ranging from 12 to 316 h for 
normal keratinocytes (epidermis), 28 to 279 h for psori­
atic involved keratinocytes (epidermis) and 28 to 149 
h for psoriatic uninvolved keratinocytes (epidermis). 
The S-phase durations show less variation between the 
various observations, ranging from 6 to 16 h and 6 to 20 
h for, respectively, normal and psoriatic (uninvolved) 
epidermis. On the one hand, the differences might be 
explained by clinical variations between patients, 
methodological errors, or statistical problems due to 
low numbers of labeled cells. On the other hand, there 
are discrepancies in the definition of the growth frac­
tion. Some authors interpret their calculations on the 
assumption that the germinative pool is identical to 
the actively cycling pool. In other words, the growth 
fraction is unity. In psoriatic epidermis and in cultures 
this might be the case, but in normal epidermis it cer­
tainly is not. Furthermore, we have to keep in mind 
that passaged keratinocytes differ from the in vivo situ­
ation in their expression of cytoskeletal proteins, mem­
brane composition, cytokine production and cell surface 
integrins (Bata-Csorgo et al., 1995).
They also differ in the composition of cells from the 
proliferative compartment, because cell cycle quiescent 
(G0) cells are underrepresented and highly cycling clo­
no genic stem cells and transit amplifying cells are over­
represented (Bata-Csorgo et al., 1995). It has also been 
demonstrated that cultures enriched in cells isolated 
from the suprabasal stratum spinosum can be cultured 
in serum-free medium (Wilke et al., 1988a). The colony- 
forming efficiency of these cultures was at least compa­
rable with cultures enriched with basal cells. It was 
even demonstrated that involucrin-containing cells 
(committed to differentiation) were able to proliferate 
in vitro. Studying cell cycle parameters in vitro means 
that we measure the parameters of a population con­
taining basal cell and suprabasal cells, these include 
“stem cells” and “transit amplifying cells.” These cells 
may differ in their growth characteristics, but the anal­
ysis finally leads to the expression of average cell cycle 
parameters.
The cell kinetic analysis that we made for normal and 
psoriatic keratinocytes uses flow cytometry combined 
with IdUrd labeling using time courses with many sam­
pling points. This methodology allows a very accurate 
determination of cell cycle parameters for each cell line. 
Obviously this study also suffers from a number of limi­
tations. Firstly, the cells that are obtained from the 
primary cultures reflect the clonogenic population in 
vitro and are not necessarily representative for the pop­
ulations in normal or psoriatic skin in vivo. Secondly,
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although the methodology used allows a very accurate 
determination of the cell cycle parameters for each cell 
line, we found that the interindividual variation of the 
cell cycle parameters found in the 5 normal cell lines 
and the 4 psoriatic cell lines is considerable (see Table 
1). From our cell kinetic analysis we conclude that there 
are no gross differences between normal and unin­
volved psoriatic keratinocytes with respect to the S- 
phase duration and total cell cycle duration. According 
to the statistical analysis we could not detect a signifi- 
cant difference between the data calculated according 
to Begg et al. (1985) and the data calculated according 
to our model. However, we prefer to use the data gener­
ated using our model since these are based on many 
time points, without making the assumptions as has 
been done by Begg et al, (1985). When we examine the 
other cell cycle parameters we can conclude that there 
are significant differences between normal and unin­
volved psoriatic keratinocytes with respect to the per­
centage of cells performing DNA synthesis and the du­
ration of the Gr phase. Psoriatic keratinocytes display 
a longer duration of the Grphase of the cell cycle and 
have a smaller percentage of cells in S-phase. This ap­
parent difference is only found when our model for cal­
culation of cell cycle parameters is used, and not when 
the method of Begg et al. (1985) is applied. This appar­
ent difference requires further examination using a 
larger series of cell lines. Our findings are in contrast 
with the data of Kragballe et al. (1985) who observed 
an increased DNA synthesis that is maintained in 
vitro, when using primary keratinocyte cultures culti­
vated on lethally irradiated 3T3 cells. Furthermore, 
they measured DNA synthesis by the incorporation of 
:3[H]-thymidine after the addition of 10% normal human 
serum. Our cell cycle data of normal keratinocytes are 
in agreement with previous investigations using differ­
ent methodology in the same serum-free culture me­
dium (van Ruissen et al., 1994; Wille et al., 1984), 
whereas we provide new data on psoriatic keratino­
cytes.
It has been described that TGF-px has potent antipro­
liferative effects on a variety of epithelial cell types 
in vitro, including keratinocytes (Moses et al., 1987; 
Matsumoto et al., 1990; Reiss and Sartorelli, 1987; 
Shipley and Pittelkow, 1987; Shipley et al., 1986). The 
inhibition of human keratinocyte proliferation in vitro 
by the addition of TGF-pi to the culture medium is 
reversible, and results in growth arrest predominantly 
in the Go/Gi-phase of the cell cycle (Reiss and Sartorelli, 
1987; Wilke et al., 1988). This growth arrest state is 
comparable to the situation in normal skin, where ap­
proximately 90% of the cells are in the Go/Gi-phase of 
the cell cycle (van Ruissen et al., 1994). On the basis 
of these investigations it has been hypothesized that 
TGF-Pi could function as a negative growth regulator 
in normal skin (Shipley et al., 1986; Wilke et al., 1988). 
It might be possible that keratinocytes derived from 
psoriatic epidermis could be deficient in either the pro­
duction of TGF-p! or the responsiveness to TGF-px re­
sulting in the characteristic hyper proliferation in psori­
asis. Investigation of the induction of quiescence 
showed that both normal and uninvolved psoriatic ker­
atinocytes can be growth-arrested within 56 hours after 
the addition of TGF-(3i. We therefore conclude that epi­
dermal hyper proliferation in psoriasis is not caused by
a decreased responsiveness of the keratinocytes to 
TGF-Pi. These results are in agreement with the data 
from Elder et al. (1990). They have shown that TGF- 
Pi mRNA expression was similar in normal epidermis 
and psoriatic lesional epidermis. They further report 
that keratinocytes derived from normal and psoriatic 
lesional epidermis do not differ in antiproliferative re­
sponsiveness to TGF-fJx and that the number of TGF- 
pj receptors per cell and binding constants are compa­
rable (Elder et al., 1990).
Quiescent keratinocyte cultures can be restimulated 
by removal of TGF-*Pi and addition of fresh growth me­
dium. To investigate if there were differences in growth 
restimulation between normal and uninvolved psori­
atic keratinocytes, we compared three cultures of each 
type. Analysis of the data suggested a difference in 
IdUrd-positive cells after 8 to 16 hours and 16 to 24 
hours of growth restimulation between normal and un­
involved psoriatic keratinocytes and not betweep -8  to 
0 hours and 0 to 8 hours. Statistical analysis did not 
show a significant difference in the kinetics of growth 
restimulation between normal and uninvolved psori­
atic keratinocytes.
From this study we can conclude that the hyperproli­
feration seen in psoriasis is not due to intrinsic differ­
ences in cell cycle duration or growth fraction between 
normal and psoriatic keratinocytes. In addition, normal 
and psoriatic keratinocytes are equally responsive to 
TGF-pt. If the hyperprolife rati ve response found in vivo 
is based on mechanisms inherent to the keratinocyte, 
it is likely to be due to factors that affect responsiveness 
to external factors (growth factor receptors, signal 
transduction pathways) rather than the “setting” of cell 
cycle times. Recent studies by Bata-Csorgo et al. (1995) 
indeed suggest that epidermal pi-integrin-positive sub­
populations are hyp erre sponsive to T-cell-derived cyto­
kines. The culture model and the methodology for anal­
ysis of proliferation, induction of quiescence, and re­
cruitment from G0 will be used for further studies on 
the involvement of T-cell-derived factors in the hyper- 
proliferative process seen psoriasis.
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